security check required facebookjoin or log into facebook   email or phonepasswordforgot accountlog indo you want to join facebooksign upsign upsecurity checkplease enter the text belowcant read the text abovetry another text or an audio captchatext in the boxwhats thissecurity checkthis is a standard security test that we use to prevent spammers from creating fake accounts and spamming userssubmitenglish usespañolfrançais franceالعربيةportuguês brasilitaliano한국어deutschहिन्दीmessengerfacebook litepeopleplacesgameslocationscelebritiesmarketplacegroupsrecipesmomentsinstagramaboutcreate adcreate pagedeveloperscareersprivacycookiesad choicestermssettingsactivity log facebook     microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows 0 click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext7400 legal privacy  cookies   microsoft adam gridley  president  chief executive officer at histogenics corp news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink adam gridley president  chief executive officer at histogenics corp overview in the news relationships paths education career history boards  committees public holdings transactions adam gridley president  chief executive officer at histogenics corp overview age  born 7 notable companies histogenics corp board seats  number of relationships this person is connected to 7 people in the news see more globenewswire july   histogenics corporation to present at the th annual canaccord genuity growth conference globenewswire june   histogenics completes enrollment for phase  clinical trial of neocartâ® to treat knee cartilage damage globenewswire june   histogenics corporation announces the appointment of donald haut phd as chief business officer globenewswire may   histogenics corporation to present at upcoming industry conferences globenewswire may   histogenics corporation receives innovation award see full news coverage and complete stories with relsci professional create your news feed see more relationships see details jonathan lieber chief financial officer at histogenics corp peter s greenleaf chairman  chief executive officer at sucampo pharmaceuticals inc garheng kong md phd advisor at sovereigns capital david n gill president  chief financial officer at endochoice inc john h johnson former chief executive officer at imclone systems inc kevin ratkin partner at highcape partners management llc josh baltzell venture partner at sightline partners llc michael lewis nonexecutive chairman board of directors at the foschini group ltd shuichi mizuno founder at histogenics corp steve basta chief executive officer  director at menlo therapeutics inc see 77 more listings with relsci professional start my free trial ➤ see 77 more paths to adam gridley adam gridley you connections via relationship science adam gridley sync your contacts to see how you can connect with adam gridley start my free trial ➤ see more educational background bs  university of denver the university of denver was founded in 4 — just a few years after the city of denver itself was founded the universitys acre campus a few miles south of downtown denver is home to more than 00 students hailing from all regions of the united states and  other countries the university offers more than 00 undergraduate programs of study and more than  graduate and professional programs mba  university of denver  daniels college of business daniels college of business originally called the school of commerce accounts and finance is established by the university of denver founded in 4 and the oldest private university in the rocky mountain region daniels is among the first business colleges in the us—a select group that includes wharton chicago berkeley dartmouth northwestern pittsburg and harvard career history president  chief executive officer   current histogenics corp histogenics corp engages in the development marketing and commercialization of musculoskeletal medicine its regenerative medicine platform combines expertise in cell processing scaffolding tissue engineering bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletalrelated conditions the company was founded on june   and is headquartered in waltham ma senior vice presidenttechnical operations    merz north america inc merz north america inc operates as an specialty healthcare company it offers treatment solutions for aesthetics dermatology and neurosciences the company was founded in 0 and is headquartered in raleigh nc senior vice presidentcorporate development 0  prior bioform medical inc bioform medical inc is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patients appearance their core product is radiesse dermal filler an injectable dermal filler designed to provide aesthetic improvement for patients the company also offers radiesse voice and radiesse voice gel for vocal fold insufficiency and coaptite as a treatment for women who have stress urinary incontinence bioform medical was founded in  and is headquartered in san mateo ca director market development 0   merz aesthetics inc merz aesthetics part of merz gmbh  co kgaa is a company headquartered in the united states that develops technology for soft and hard tissue augmentation director business development   0 gliatech inc gliatech inc engages in the discovery and development of bio surgery and pharmaceutical products the company was founded on august  7 and is headquartered in cleveland oh boards  committees corporate boards ▾ member board of directors   current histogenics corp histogenics corp engages in the development marketing and commercialization of musculoskeletal medicine its regenerative medicine platform combines expertise in cell processing scaffolding tissue engineering bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletalrelated conditions the company was founded on june   and is headquartered in waltham ma public holdings restricted data only for relsci professional users start my free trial ➤ see more transactions details hidden histogenics corp raised money in a private placement transaction other affiliations adam gridley is affiliated with histogenics corp merz north america inc bioform medical inc merz aesthetics inc gliatech inc histogenics corp youve reached your 0 free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ adam gridley  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in adam gridley dir president and chief executive officer at histogenics view full profile are you adam gridley claim your profile   sign up for equilar atlas and view adam gridleys full profile with equilar atlas you can identify corporate executives in adam gridleys network and community follow changes in adam gridleys employment and moneyinmotion connect with adam gridley through your network of contacts adam gridleys executive work history current dir president and chief executive officer histogenics past to view adam gridleys complete executive work history sign up now education bs university of denver age      adam gridleys biography adam gridley has served as our chief executive officer and president since may  mr gridley previously served from october  until may  as senior vice president of technical operations at merz north america inc the north american business unit of merz inc a privatelyheld pharmaceuticals company from september  to october  he was senior vice president operations  product development responsible for global research and development and manufacturing for merz aesthetics inc a global business unit of merz inc and from july 0 to september  mr gridley held the position of senior vice president product d  read more adam gridley has served as our chief executive officer and president since may  mr gridley previously served from october  until may  as senior vice president of technical operations at merz north america inc the north american business unit of merz inc a privatelyheld pharmaceuticals company from september  to october  he was senior vice president operations  product development responsible for global research and development and manufacturing for merz aesthetics inc a global business unit of merz inc and from july 0 to september  mr gridley held the position of senior vice president product development at merz from september 0 to july 0 mr gridley was senior vice president corporate development for bioform medical inc a publiclytraded company acquired by merz inc mr gridley holds a bs and an mba from the university of denver we believe that mr gridleys qualifications to serve as a director of our company include his extensive experience as an executive in the biotechnology industry and his prior service as a seniorlevel executive in both early stage and mature biotechnology companies source histogenics on    sign up for equilar atlas and view adam gridleys full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like adam gridley more specifically youll be able to identify corporate executives in adam gridleys network and community follow changes in adam gridleys employment and moneyinmotion connect with adam gridley through your network of conections view full profile   search for over 0 executive profiles bio example adam gridley adam gridleys connections  sign up now to view adam gridleys  connections » michael lewis board member histogenics jeffrey m nugent former chairman of the board and chief executive officer sientra inc kevin rakin board member histogenics john h johnson board member cempra inc martin p sutter board member abiomed derek a bertocci former senior vice president and chief financial officer achaogen inc garheng kong board member cempra inc albert cha board member kalvista pharmaceuticals inc peter s greenleaf chief executive officer and chairman of the board sucampo pharmaceuticals inc joshua j baltzell board member entellus medical inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy 00 marshall street redwood city ca 40  phone 0 4  fax 0 700 histogenics announces appointment of adam gridley to president and chief executive officer histogenics home    press releases    histogenics announces appointment of adam gridley to president and chief executive officernews press releases histogenics announces appointment of adam gridley to president and chief executive officer may  pharmaceutical executive brings extensive product development  operational expertise to latestage regenerative medicine company waltham ma may  —histogenics corporation a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space today announced the appointment of adam gridley to president and chief executive officer and as a member of the company’s board of directors mr gridley brings over  years of proven results in the medical device and pharmaceutical industries with a combination of transactional and public markets experience as well as strong operational leadership and product development expertise mr gridley’s career has focused on strategic elements of corporate growth with a demonstrated and successful track record in strategic planning manufacturing and rd expansions and corporate and technology integrations “adam’s expertise in growing and leading biotech companies and rd organizations will be critical as we progress our lead investigational product neocart® through a phase  pivotal trial and ultimately toward potential approval and commercialization” said the company’s chairman garheng kong “we believe that adam’s proven leadership will facilitate our company’s vision of leveraging our regenerative medicine platform to become an emerging leader in the musculoskeletal and orthopedics space” continued dr kong “i am excited to join histogenics as the company builds out its operational functions technology platform and commercial infrastructure i believe that histogenics has a significant opportunity with its lead investigational product neocart® which has the potential to become an innovative therapy alternative to the current standard of care for cartilage repair in the knee” said mr gridley “the management team investors and board of directors at histogenics has done an outstanding job supporting neocart’s ongoing phase  trial in the us and i look forward to leading the company through this pivotal stage of strategic growth and development” prior to joining histogenics mr gridley most recently served as senior vice president technical operations at merz a privatelyheld specialty healthcare company focused on the development and commercialization of products for aesthetics dermatology and neurosciences where he was a global site head responsible for manufacturing and quality operations information technology and sourcing activities previously mr gridley was senior vice president of corporate development for bioform medical inc a publicallytraded company that was acquired by merz in 0 in this role mr gridley was responsible for all business development investor relations strategic planning product development activities and rd functions for the organization prior to that mr gridley held several key strategic leadership roles in the orthopedics space during his career including director of business development and investor relations at gliatech inc mr gridley holds a bachelor of science and a master of business administration from the university of denver about histogenics histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace our regenerative medicine platform combines expertise in cell processing scaffolding tissue engineering bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletalrelated conditions our first investigational product candidate neocart® leverages our platform to provide an innovative treatment in the orthopedic space specifically cartilage damage in the knee for more information on histogenics please visit the company website at wwwhistogenicscom about neocart neocart® our phase  investigational product is an implant produced using a patient’s own cartilage cells a phase  clinical trial conducted in the united states demonstrated favorable preliminary results which supported proceeding to a phase  clinical trial a phase  clinical trial conducted in the united states comparing neocart® to the standardofcare microfracture met its endpoints for safety and for improvement in pain and function these results support the continued clinical development of neocart® the twoyear results of our phase  clinical trial are publicly available crawford et al j bone joint surg am 47 a phase  clinical trial conducted in the united states comparing neocart® to the standardofcare microfracture is currently in progress information about the study is available on httpwwwneocartimplantcom and httpwwwclinicaltrialsgov for additional inquiries please email us at investorrelationshistogenicscom or call us at 747700 forward looking statement this press release contains “forward looking statements” including statements about histogenics’ future operating results product development potential alliances and intellectual property forwardlooking statements involve known and unknown risks uncertainties and other factors that may cause our actual results performance or achievements to be materially different from any future results performances or achievements expressed or implied by the forwardlooking statements  winter street rd floor waltham ma 04 tel 747700 fax 747 email investorrelationshistogenicscom about us history management board of directors scientific advisory board products  platform products  platform neocart platform about regenerative medicine about cartilage repair investors investor overview stock information analysts sec filings calendar of events corporate governance investor faqs news press releases contact contact career opportunities adam gridley president  ceo histogenics timesjavascript is disabled market profiles login sign up login sign up   edit person adam gridley president  ceo at histogenics location boston ma add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop adam gridley president  ceo at histogenics location boston ma add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop mr adam gridley has over  years of proven results in the medical device biotechnology and pharmaceutical industries mr gridley’s career includes a combination of transactional and public markets experience as well as deep operational leadership and product development expertise a strong interactive leader with significant experience in venture backed startups to large multinational pharmaceutical organizations mr gridley has led several products through the development and regulatory approval phases into commercialization by building and leading functionally diverse global teams his strong experience in manufacturing and quality operations has also facilitated the worldwide regulatory approvals of several diverse manufacturing sites focused on raising growth capital and enhancing shareholder value mr gridley has managed venture capital and public offerings and led many business development transactions with companies such as boston scientific wright medical merck and abgenix before joining the histogenics team mr gridley served in several senior roles of increasing responsibility at merz a privatelyheld specialty healthcare company focused on the development and commercialization of products for aesthetics dermatology and neurosciences where he was most recently senior vice president of technical operations during his time at merz he served as the global site head responsible for a variety of functions including rd manufacturing quality operations finance and it previously mr gridley was senior vice president of corporate development for bioform medical inc a publiclytraded company that was acquired by merz in 0 his responsibilities included all business development investor relations strategic planning and rd functions and he was part of the leadership team who led the company’s ipo and subsequent acquistion by merz mr gridley has held several key strategic leadership roles in the orthopedics space during his career including director of business development and investor relations at gliatech inc mr gridley holds a bachelor of science and a master of business administration from the university of denver  companies in career na related markets  colleagues na related investments alias na industry medical device equipment supplies manufacturing tags business development product development investor relations corporate development strategy topics of influence na na careers achievements investments related people edit view all adam gridleycareer  may histogenics president  ceo oct to may merz north america senior vice president technical operations sep to oct merz aesthetics senior vice president operations  product development sep0 to aug0 bioform medical senior vice president corporate development jul0 to sep0 bioform medical vice president corporate development may to jul0 bioform medical director of corporate development competencies edit view all adam gridleyeducation   university of denver 4 university of denver accounting edit adam gridleyachievements and recognitions add milestone no milestones has been recorded for adam gridley edit adam gridleylinks add link no links has been recorded for adam gridley adam gridleyinvestmentsacquisitions no investments has been recorded for adam gridley adam gridleyinvestments representing others no investment reps has been recorded for adam gridley adam gridleyrelated people colleagues at histogenics donald haut chief business officer jun view all adam gridleyrecommended market profiles  telemedicine 0 or more employees  companies social media marketing chiefmarteccom   0 employees  companies big data universe list of lists 0 or more employees  companies aggregated marketing technology 0 or more employees 0 companies shared economy landscape jeremiah owyang 0 or more employees 7 companies inside sales landscape 0 or more employees 0 companies